FOXG1 holds the key to unlock brain disorders affecting millions, 
including autism, Alzheimer's, brain tumors and many more.

 

FOXG1 is an excellent candidate for gene therapy and biotech investment.

 

 Scientific Advisory Board

Orrin Devinsky, MD  Neurosurgeon, NYU Langone, Chief of Service, NYU Epilepsy

Orrin Devinsky, MD
Neurosurgeon, NYU Langone, Chief of Service, NYU Epilepsy

Robin Kleiman, Ph.D  Senior Director, Biogen Research Associate, Boston Children’s Hospital

Robin Kleiman, Ph.D
Senior Director, Biogen Research Associate, Boston Children’s Hospital

Kiran Reddy, MD  CEO, Praxis Precision Medicines, Former Partner, Clarus Ventures

Kiran Reddy, MD
CEO, Praxis Precision Medicines, Former Partner, Clarus Ventures

Aris Economides, PhD  Vice President of Research, Regeneron Pharmaceuticals

Aris Economides, PhD
Vice President of Research, Regeneron Pharmaceuticals

Steven Gray, PhD  Scientist, Gene Therapy Center at UNC School of Medicine

Steven Gray, PhD
Scientist, Gene Therapy Center at UNC School of Medicine

Ingrid Scheffer, MD, PhD  Neurologist and Senior Research Fellow, Florey Institute of Neuroscience and Mental Health

Ingrid Scheffer, MD, PhD
Neurologist and Senior Research Fellow, Florey Institute of Neuroscience and Mental Health

Elli Brimble, MSc, MS, CGC  Geneticist, Lucille Packard Children’s Hospital at Stanford

Elli Brimble, MSc, MS, CGC
Geneticist, Lucille Packard Children’s Hospital at Stanford

Neil Kumar, PhD  CEO, BridgeBio Pharma, Former Principal, Third Rock Ventures

Neil Kumar, PhD
CEO, BridgeBio Pharma, Former Principal, Third Rock Ventures

Heather Olson, MD, MS  Neurologist, Boston Children's; Neurology Instructor, Harvard Medical

Heather Olson, MD, MS
Neurologist, Boston Children's; Neurology Instructor, Harvard Medical

Xilma Ortiz-Gonzalez, MD, PhD  Pediatric Neurologist, CHOP, Neurology Instructor, University of Pennsylva

Xilma Ortiz-Gonzalez, MD, PhD
Pediatric Neurologist, CHOP, Neurology Instructor, University of Pennsylva

Mary Jones, MD  Pediatrician, Head, Katie's RETT Clinic at UCSF Oakland

Mary Jones, MD
Pediatrician, Head, Katie's RETT Clinic at UCSF Oakland

Gordon Fishell, PhD  Scientist, Broad Institute; Professor, Harvard Medical School

Gordon Fishell, PhD
Scientist, Broad Institute; Professor, Harvard Medical School

 
Hourinaz Behesti, PhD  Developmental Neurobiologist, Rockefeller University

Hourinaz Behesti, PhD
Developmental Neurobiologist, Rockefeller University

Toni Cathomen, PhD   Director, Institute for Cell and Gene Therapy, University of Freiburg

Toni Cathomen, PhD
Director, Institute for Cell and Gene Therapy, University of Freiburg

Ritu Lal, PhD   Clinical Pharmacology Consultant

Ritu Lal, PhD
Clinical Pharmacology Consultant

Mark Pykett, PhD  Chief Innovation Officer, PTC Therapeutics, former CEO, Agilis Biotherapeutics

Mark Pykett, PhD
Chief Innovation Officer, PTC Therapeutics, former CEO, Agilis Biotherapeutics


Dr Nadia Bahi-Buisson, MD, PhD  Pediatric Neurology, Necker Enfants Malades University Hospital, Paris

Dr Nadia Bahi-Buisson, MD, PhD
Pediatric Neurology, Necker Enfants Malades University Hospital, Paris